435 related articles for article (PubMed ID: 14654533)
1. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer.
Onn A; Isobe T; Wu W; Itasaka S; Shintani T; Shibuya K; Kenji Y; O'reilly MS; Fidler IJ; Herbst RS
Clin Cancer Res; 2004 Dec; 10(24):8613-9. PubMed ID: 15623645
[TBL] [Abstract][Full Text] [Related]
3. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
Ishii H; Yazawa T; Sato H; Suzuki T; Ikeda M; Hayashi Y; Takanashi Y; Kitamura H
Lung Cancer; 2004 Sep; 45(3):325-37. PubMed ID: 15301873
[TBL] [Abstract][Full Text] [Related]
5. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.
McLemore TL; Liu MC; Blacker PC; Gregg M; Alley MC; Abbott BJ; Shoemaker RH; Bohlman ME; Litterst CC; Hubbard WC
Cancer Res; 1987 Oct; 47(19):5132-40. PubMed ID: 3621199
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice.
McLemore TL; Eggleston JC; Shoemaker RH; Abbott BJ; Bohlman ME; Liu MC; Fine DL; Mayo JG; Boyd MR
Cancer Res; 1988 May; 48(10):2880-6. PubMed ID: 3359444
[TBL] [Abstract][Full Text] [Related]
7. An orthotopic nude mouse model of oral tongue squamous cell carcinoma.
Myers JN; Holsinger FC; Jasser SA; Bekele BN; Fidler IJ
Clin Cancer Res; 2002 Jan; 8(1):293-8. PubMed ID: 11801572
[TBL] [Abstract][Full Text] [Related]
8. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J
Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
13. Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer.
Kang Y; Omura M; Suzuki A; Oka T; Nakagami Y; Cheng C; Nagashima Y; Inoue T
Cancer Sci; 2006 Oct; 97(10):996-1001. PubMed ID: 16984373
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor-1 influences sensitivity to paclitaxel of human lung cancer cell lines under normoxic conditions.
Zeng L; Kizaka-Kondoh S; Itasaka S; Xie X; Inoue M; Tanimoto K; Shibuya K; Hiraoka M
Cancer Sci; 2007 Sep; 98(9):1394-401. PubMed ID: 17608771
[TBL] [Abstract][Full Text] [Related]
15. SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cells.
Miyoshi T; Kondo K; Ishikura H; Kinoshita H; Matsumori Y; Monden Y
Anticancer Res; 2000; 20(1A):161-3. PubMed ID: 10769649
[TBL] [Abstract][Full Text] [Related]
16. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
Harper E; Dang W; Lapidus RG; Garver RI
Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
[TBL] [Abstract][Full Text] [Related]
17. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
He DM; Zhang H
Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
[TBL] [Abstract][Full Text] [Related]
20. Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice.
Goto H; Yano S; Zhang H; Matsumori Y; Ogawa H; Blakey DC; Sone S
Cancer Res; 2002 Jul; 62(13):3711-5. PubMed ID: 12097279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]